336 related articles for article (PubMed ID: 19178935)
1. Differentiation and functional analysis of human T(H)17 cells.
Burgler S; Ouaked N; Bassin C; Basinski TM; Mantel PY; Siegmund K; Meyer N; Akdis CA; Schmidt-Weber CB
J Allergy Clin Immunol; 2009 Mar; 123(3):588-95, 595.e1-7. PubMed ID: 19178935
[TBL] [Abstract][Full Text] [Related]
2. The Th17/Treg imbalance in patients with acute coronary syndrome.
Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH
Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918
[TBL] [Abstract][Full Text] [Related]
3. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
4. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.
Acosta-Rodriguez EV; Napolitani G; Lanzavecchia A; Sallusto F
Nat Immunol; 2007 Sep; 8(9):942-9. PubMed ID: 17676045
[TBL] [Abstract][Full Text] [Related]
5. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
Crome SQ; Wang AY; Kang CY; Levings MK
Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
[TBL] [Abstract][Full Text] [Related]
6. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
[TBL] [Abstract][Full Text] [Related]
9. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
10. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells.
Chen H; Qin J; Wei P; Zhang J; Li Q; Fu L; Li S; Ma C; Cong B
Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):195-200. PubMed ID: 19264469
[TBL] [Abstract][Full Text] [Related]
11. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
12. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
[TBL] [Abstract][Full Text] [Related]
13. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23.
Aliahmadi E; Gramlich R; Grützkau A; Hitzler M; Krüger M; Baumgrass R; Schreiner M; Wittig B; Wanner R; Peiser M
Eur J Immunol; 2009 May; 39(5):1221-30. PubMed ID: 19350551
[TBL] [Abstract][Full Text] [Related]
14. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity.
Ichiyama K; Hashimoto M; Sekiya T; Nakagawa R; Wakabayashi Y; Sugiyama Y; Komai K; Saba I; Möröy T; Yoshimura A
Int Immunol; 2009 Jul; 21(7):881-9. PubMed ID: 19505891
[TBL] [Abstract][Full Text] [Related]
15. Targeting the development and effector functions of TH17 cells.
Ghilardi N; Ouyang W
Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
[TBL] [Abstract][Full Text] [Related]
16. RORC2: the master of human Th17 cell programming.
Unutmaz D
Eur J Immunol; 2009 Jun; 39(6):1452-5. PubMed ID: 19499530
[TBL] [Abstract][Full Text] [Related]
17. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
18. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.
Maggi L; Santarlasci V; Capone M; Peired A; Frosali F; Crome SQ; Querci V; Fambrini M; Liotta F; Levings MK; Maggi E; Cosmi L; Romagnani S; Annunziato F
Eur J Immunol; 2010 Aug; 40(8):2174-81. PubMed ID: 20486123
[TBL] [Abstract][Full Text] [Related]
19. IL-1beta and IL-2 convert human Treg into T(H)17 cells.
Deknuydt F; Bioley G; Valmori D; Ayyoub M
Clin Immunol; 2009 May; 131(2):298-307. PubMed ID: 19211307
[TBL] [Abstract][Full Text] [Related]
20. T(H)-17 cells in the circle of immunity and autoimmunity.
Bettelli E; Oukka M; Kuchroo VK
Nat Immunol; 2007 Apr; 8(4):345-50. PubMed ID: 17375096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
